Boku extends its M1ST Payments Network into Thailand with TrueMoney & Rabbit LINE Pay
November 18, 2021 03:00 ET
|
Boku Inc.
LONDON, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Boku Inc., (AIM: BOKU), provider of M1ST, the world’s largest mobile payments network has today announced the expansion of M1ST into Thailand, with the...
Amydis Receives NIH Grant Award to Develop a Novel Tau Retinal Tracer for Alzheimer's Diseases and other Tauopathies
September 02, 2021 07:00 ET
|
Amydis, Inc.
SAN DIEGO, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Amydis Inc., a leading ocular tracer pharmaceutical company with a broad portfolio of diagnostic drug candidates targeting CNS biomarkers in the eye,...
Retrotope Announces Completion of Enrollment in Phase 2 Study of RT001 in Patients with Progressive Supranuclear Palsy (PSP)
August 11, 2021 07:00 ET
|
Retrotope
LOS ALTOS, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Retrotope, a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class therapies for degenerative diseases,...
Retrotope Announces Initiation of Phase 2 Study of RT001 in Patients with Progressive Supranuclear Palsy (PSP)
June 30, 2021 07:00 ET
|
Retrotope
LOS ALTOS, Calif., June 30, 2021 (GLOBE NEWSWIRE) -- Retrotope, a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class therapies for degenerative diseases,...
Canadian Long Term Care Company Tax Dodging to Boost Profits According to a New Report by CICTAR
January 28, 2021 09:45 ET
|
CICTAR
OTTAWA, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Canada’s second largest long term care home operator, Revera, appears to use aggressive tax avoidance schemes in the UK, according to a new report, Tax...
US FDA Grants Orphan Drug Designation for Retrotope’s RT001 in the Treatment of Progressive SupraNuclear Palsy (PSP)
February 18, 2020 16:10 ET
|
Retrotope
LOS ALTOS, Calif., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Retrotope announced today that the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development granted orphan drug designation...
Biogen Reports Top-Line Results from Phase 2 Study in Progressive Supranuclear Palsy
December 13, 2019 07:30 ET
|
Biogen Inc.
CAMBRIDGE, Mass., Dec. 13, 2019 (GLOBE NEWSWIRE) -- Today, Biogen Inc. (Nasdaq: BIIB) announced topline results from the Phase 2 PASSPORT study of gosuranemab (BIIB092) for progressive supranuclear...
Dazzboard Brings Device Management to Social Networking With Facebook App
August 12, 2009 09:05 ET
|
Dazzboard
SAN JOSE, CA--(Marketwire - August 12, 2009) - Dazzboard, the ultimate social media webtop,
today expanded its online services with the release of a Facebook app. As
one of the leading social media...